Press release - 23/06/2008 Doubts about TNF-alpha blockers Results obtained by scientists at the Department of Orthopaedic Surgery at the University Hospital of Heidelberg show that in contrast to previous assumptions the tumour necrosis factor alpha TNF-alpha has no influence on pain and mobility.https://www.gesundheitsindustrie-bw.de/en/article/press-release/doubts-about-tnf-alpha-blockers
Article - 22/06/2008 Nycomed sells oncology programs to 4SC Eight projects in the preclinical and first clinical stage will be transferred to 4SC. Nycomed decided not to further invest in oncology RD activities. 4SC develops drug candidates for inflammatory diseases cancer and infectious diseases.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-sells-oncology-programs-to-4sc
Article - 21/06/2008 Hartmann continues profitable growth The Hartmann Group based in Heidenheim continues to grow in the first quarter of 2008. Sales increased 6.3 over the last year sales volume increased 7.1. The company expects further growth in sales and volume for the year 2008. https://www.gesundheitsindustrie-bw.de/en/article/news/hartmann-continues-profitable-growth
Article - 21/06/2008 Wanting children without risk In Germany one couple in ten is unable to conceive naturally. There are a number of different in vitro fertilisation methods available for those who wish to have children. However the potential risks to the child are still unknown.https://www.gesundheitsindustrie-bw.de/en/article/news/wanting-children-without-risk
Article - 20/06/2008 No unanimous feedback possible At the beginning of the year 2009 the first bachelors degree students will graduate from Furtwangen University of Applied Science in disciplines including bio- and process technology BPT and medical technology MEB. What does the first generation of bachelors students think about their life sciences courses? Karin Bundschuh from the Freiburg BioRegion talked with the Universitys academic dean Professor Anton Karle and some students. https://www.gesundheitsindustrie-bw.de/en/article/news/no-unanimous-feedback-possible
Article - 20/06/2008 Zeiss expects successful end to first six months of 2007/2008 The optics and electronics specialist Carl Zeiss AG Oberkochen is optimistic about the first six months of 20072008 30th September despite decreasing investment activity in the semiconductor industry. For the second six months the company expects a slight slowdown in the revenues the company generates in this business group. In the first half of the fiscal year the Semiconductor Technology Group recorded further strong growth up 16 and generated…https://www.gesundheitsindustrie-bw.de/en/article/news/zeiss-expects-successful-end-to-first-six-months-of-2007-2008
Press release - 20/06/2008 Refusal of Suicide Order: Why Tumor Cells Become Resistant Cells with irreparable DNA damage normally induce programmed cell death, or apoptosis. However, this mechanism often fails in tumor cells so that transformed cells are able to multiply and spread throughout the body. Scientists at the German Cancer Research Center have now discovered a possible cause of this failure. https://www.gesundheitsindustrie-bw.de/en/article/press-release/refusal-of-suicide-order-why-tumor-cells-become-resistant
Article - 17/06/2008 "Study and work abroad!”" Quick practically oriented and above all international The new bachelor and masters degrees in the natural sciences have been introduced to bring German university qualifications into line with the requirements of the international job market as well as to facilitate the uncomplicated exchange of scientists across the globe. However not everything always works out as planned. Research abroad is often limited by time and money.https://www.gesundheitsindustrie-bw.de/en/article/news/study-and-work-abroad
Press release - 16/06/2008 Five Health Regions in Baden-Württemberg are finalists Among the 20 winners in the first round of the BMBF contest Health Regions of the Future were five concepts from Baden-Württemberg. In the coming nine months the chosen health regions will turn their concepts into full proposals.https://www.gesundheitsindustrie-bw.de/en/article/press-release/five-health-regions-in-baden-wuerttemberg-are-finalists
Article - 16/06/2008 Apogenix raises 27.5 million euros Apogenix GmbH a biopharmaceutical company announced the closing of its second financing round. dievini Hopp BioTech holding GmbH Co. KG the investment company of SAP co-founder Dietmar Hopp was the main investor.https://www.gesundheitsindustrie-bw.de/en/article/news/apogenix-raises-27-5-million-euros
Article - 16/06/2008 Medical trial: reduced bleeding after stroke Cerebral haemorrhage accounts for about 15 per cent of all incidences of stroke. About 80 per cent of survivors are left with a severe disability. An international trial has shown that the Factor VIIa protein might reduce the extent of cerebral haemorrhage.https://www.gesundheitsindustrie-bw.de/en/article/press-release/medical-trial-reduced-bleeding-after-stroke
Article - 14/06/2008 Cancer researchers kind Key molecule for tumor cachexia Many cancer patients lose a lot of weight Free fatty acids accumulate in the liver and this eventually leads to fatty liver in affected patients. What is called tumor cachexia appears to be caused by signals emitted by the tumor itself.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cancer-researchers-kind-key-molecule-for-tumor-cachexia
Article - 14/06/2008 Guide to active drug ingredients and pharmaceuticals manufacturers The interdisciplinary team in the Clinical Pharmacy Cooperation Unit at the University Hospital of Heidelberg has developed a tool for preventing errors when medication is changed.https://www.gesundheitsindustrie-bw.de/en/article/news/guide-to-active-drug-ingredients-and-pharmaceuticals-manufacturers
Article - 14/06/2008 ResearchGATE - "Facebook" for researchers ResearchGATE which was launched at the end of May 2008 is a free web-based science environment for scientists. Registered users can set up their personal profiles and present their scientific work as well as exchange information with other scientists. https://www.gesundheitsindustrie-bw.de/en/article/press-release/researchgate-facebook-for-researchers
Article - 13/06/2008 Basic research with a focus on application In the Centre of Applied Photonics CAP at the University of Constance interdisciplinary teams of researchers are working on new optical technologies with a special focus on laser technology. https://www.gesundheitsindustrie-bw.de/en/article/news/basic-research-with-a-focus-on-application
Article - 10/06/2008 Heiko Möller - Uncovering molecular structures Professor Heiko Möller teaches chemistry at the University of Constance and is a specialist in nuclear magnetic resonance spectroscopy. He enjoys working with other people including colleagues from the field of chemistry and also biologists and tropical disease specialists. Möller returned from the USA to accept a junior professor position at Constance University.https://www.gesundheitsindustrie-bw.de/en/article/news/heiko-moeller-uncovering-molecular-structures
Article - 09/06/2008 The brain can learn to hear again Cochlear implants can restore hearing to many of those afflicted with deafness. Prof. Robert Illing from the University of Freiburg explores the plastic properties of the nervous system that facilitate the application of these implants.https://www.gesundheitsindustrie-bw.de/en/article/news/the-brain-can-learn-to-hear-again
Article - 09/06/2008 Moderate growth In 2007 the German biotechnology sector was marked by moderate growth. Turnover climbed over two billion euros and research and development expenditure reached one billion euros. These are the central findings of the latest company survey carried out by biotechnologie.de.https://www.gesundheitsindustrie-bw.de/en/article/news/moderate-growth
Press release - 09/06/2008 Russian-German funding competition Deadline for submitting preliminary proposals written in English is the 30th June 2008.https://www.gesundheitsindustrie-bw.de/en/article/press-release/russian-german-funding-competition
Article - 08/06/2008 New mechanism for the disaggregation of protein aggregates Prof. Bernd Bukaus team from the Centre for Molecular Biology at the University of Heidelberg has succeeded for the very first time in gaining an understanding of the molecular mechanisms that enable cells to dissolve stress-related protein aggregates. https://www.gesundheitsindustrie-bw.de/en/article/news/new-mechanism-for-the-disaggregation-of-protein-aggregates
Article - 08/06/2008 BVMed companies to found “Cataract Initiative” Companies of the German Medical Technology Association BVMed have founded the Cataract Initiative an information platform for patients and other interested parties that provides information on the benefits of modern intraocular lenses.https://www.gesundheitsindustrie-bw.de/en/article/news/bvmed-companies-to-found-cataract-initiative
Article - 07/06/2008 Gene mutations affect the chances of being cured of leukaemia Scientists at the University Hospital of Ulm and the Hanover Medical School MHH have succeeded in deciphering genetic defects in patients suffering from acute myeloid leukaemia. Their findings allow for more individualised therapies in the future.https://www.gesundheitsindustrie-bw.de/en/article/press-release/gene-mutations-affect-the-chances-of-being-cured-of-leukaemia
Article - 07/06/2008 Life-saving surgery for high-risk patients A new surgical repair of the aorta that obviates the necessity to open the thorax and the abdominal cavity is highly suited to high-risk patients that could not previously be operated due to concomitant diseases or previous surgery. https://www.gesundheitsindustrie-bw.de/en/article/news/life-saving-surgery-for-high-risk-patients
Press release - 06/06/2008 Collaborative research centre on cardiac diseases to receive further funding The German Research Foundation will continue to fund the Transregional Collaborative Research Centre Inflammatory Cardiomyopathy - Molecular Pathogenesis and Therapy for another four years with a total of 10 million euros. The Department of Cardiology of the University Hospital of Tübingen will also become part of the SFB.https://www.gesundheitsindustrie-bw.de/en/article/press-release/collaborative-research-centre-on-cardiac-diseases-to-receive-further-funding
Article - 05/06/2008 CureVac: partnership with University of Florida, CureVac GmbH has entered into a partnership with the Department of Urology University of Florida Gainesville U.S. to jointly advance its lead candidate CV9103 into the clinical development. The alliance covers preclinical studies and a US phase III trial.https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-partnership-with-university-of-florida